Semaglutide vs MOTS-c
A detailed side-by-side comparison of Semaglutide and MOTS-c covering dosing, storage, research findings, and practical usage.
Overview
Semaglutide: A GLP-1 receptor agonist used for weight management and blood sugar control.
MOTS-c: A mitochondrial-derived peptide that regulates metabolic homeostasis and exercise mimetic.
Comparison Table
| Property | Semaglutide | MOTS-c |
|---|---|---|
| Category | GLP-1 Agonist | Metabolic & Longevity |
| Typical Dose | 250-2500 mcg | 5000-10000 mcg |
| Frequency | 1x per week | 3-5x per week |
| Half-Life | ~7 days | Unknown |
| Timing | Same day each week, any time of day | Morning, preferably before exercise |
Semaglutide Research
Semaglutide is an FDA-approved GLP-1 receptor agonist originally developed for Type 2 diabetes (Ozempic) and later approved for chronic weight management (Wegovy). It mimics the hormone GLP-1, which regulates appetite, food intake, and blood sugar levels. Clinical trials have demonstrated impressive weight loss results, with participants losing an average of 15-17% of body weight over 68 weeks. Semaglutide works by slowing gastric emptying, reducing appetite, and improving insulin sensitivity. It also shows cardiovascular benefits, reducing major adverse cardiac events in at-risk patients. The once-weekly dosing makes it convenient compared to daily alternatives.
Semaglutide Full Guide | MOTS-c Full Guide | Dosage Calculator | Shop Peptides
For laboratory research use only. Not for human consumption.